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SUMMARY 
We investigated the antiplasmodial activity of some pure compounds of Turreanthus 
africanus (Meliaceae), a plant that is used in traditional medicine to treat malaria in 
Southwest Cameroon. A phytochemical analysis of the methylene chloride: 
methanol (1:1) extract of the seeds of the plant yielded seven compounds. Four of 
them, which were oils, were subjected to in vitro bioassays on Plasmodium 
falciparum F 32, chloroquine sensitive strain. Compound 1 (16-oxolabda-8 (17), 
12(E)-dien-15-oic acid), showed the highest antiplasmodial activity, two others 
(methyl-14,15-epoxylabda-8 (17), 12(E)-diene-16-oate, and turreanin A), had 
moderate activity and one was inactive. These findings are consistent with the use of 
T. africanus in the traditional treatment of P. falciparum malaria. 
 
[Afr J Health Sc, 2006; 13: 33-39] 
 
Introduction 
The high burden of malaria with an estimated 
300 to 500 million cases and a mortality rate of 
about a million deaths annually mostly in 
children is increasing [1, 2, 3]. Plasmodium 
falciparum causes the most severe form of 
malaria and is responsible for the majority of all 
clinical cases [4]. Its control in recent years has 
been rendered more difficult by the emergence 
and spread of drug resistant strains [5, 6]. 
Medicinal plants are widely used in the 
treatment of microbial infections in African 
traditional medicine [7] and some of these plants 
have been shown to have considerable 
antimalarial activity [8, 9, 10]. In continuation of 
our search for new antiplasmodial agents from 
plant sources, we investigated the compounds 
isolated from Turreanthus africanus 
(Meliaceae), a timber tree of the rainy forests of 
West and Central Africa. In Cameroonian 
traditional medicine, the trunk bark and seeds of 
this plant are boiled together with Carica 
papaya (Caricaceae) leaves, the seeds of 
Aframomum melegueta (Zingiberaceae)  and 
lime and used for treatment of malaria and other 
fevers, by drinking and or as a steam bath. The 
bark of this tree is also used as a fish poison in 
small freshwater streams. It is also said to have 
insecticidal activity. Some of the compounds 
isolated from this plant have been described 
from Renealmia alpinia (Zingiberaceae) and are 
known to have cytotoxic activity [11]. Herein, 
we report on the     antiplasmodial activities of 
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Materials and Methods 
Plant Material 
The seeds of T. africanus were collected in Buea 
on the flanks of Mount Cameroon in August 
2003, and authenticated by Mr. Ndive Elias, a 
Botanist of the Limbe Botanic Garden, 
Cameroon, where a voucher specimen was 
deposited. 
 
Extraction and Isolation                        
The air- dried and coarsely ground seeds (3.5 
kg) of T. africanus were defatted in hexane for 
48 hours, followed by maceration in methylene 
chloride: methanol mixture (1:1) for 5 days. 
Filtration and concentration in vacuo on a rotary 
evaporator yielded 150 g of extract, which was 
subjected to vacuum liquid chromatography on 
silica gel, eluting with a gradient of ethylacetate 
in hexane. This gave seven major fractions, 
which were variously purified by gel permeation 
through Sephadex LH-20 (CH2Cl2 and/or 
CH2Cl2/MeOH), and collecting 50 ml for each 
elution. Fraction 1 obtained by 10–15 % 
ethylacetate in hexane afforded 16-oxolabda-8 
(17), 12(E)-dien-15-oic acid, 1 (22 mg), as an 
orange oil [11], while fraction 2  (20-25% 
ethylacetate in hexane) gave methyl-14, 15-
epoxylabda-8 (17), 12(E)-diene-16-oate, 2 (150 
mg), as a yellowish oil and turreanin A, 3 (100 
mg), as an orange oil, shown in Figure 1,  
[12,13].  
 
                                  Fig 1. Chemical structures of three of the four pure compounds isolated  
                                            from Turreanthus africanus 












Preparation of Solutions  
The compounds were weighed (10 mg of each) 
and dissolved in 100 to 200 µl 
dimethylsulphoxide (DMSO) at 37° C overnight, 
then sterile gentamycin-free medium (RPMI 
1640), was added to give stock solutions of  
1 mg/ml final concentration. The stock solutions 
were sterile-filtered through 0.45 µm filter and 
stored in the dark at 4° C. Chloroquine 
diphosphate (1 mg/ml) was prepared similarly. 
 
Culture of the Malaria Parasite  
Plasmodium falciparum F32 strain 




Tanzania was used in this study. This strain has 
been cultured and maintained in the Department  
of Immunology, Stockholm University, Sweden. 
The parasite was cultured by the candle jar  
technique of Trager and Jensen [14], using 
malaria culture medium (MCM: 10.43 g RPMI 
1640, 2 g NaHCO3, and 0.5 ml of 50 mg/ml 
Gentamycin, per litre of double distilled water, 
with 10% human serum), group O+ erythrocytes 
and incubated at 37O C. Synchronization and 
subculturing  of the parasite  were done as 
previously described [15] and synchonised 
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In Vitro Growth Inhibition Assay  
This was done as described with some 
modification [16]. 100 µl of sterile RPMI 
(gentamycin-free) was added in duplicate to all 
required wells in a 96 well flat-bottom plate 
(Costar, Corning, NY), 100 µl of extract solution 
was doubled diluted in the wells to give 
concentrations from 250 to 2 µg/ml.  
Chloroquine diphosphate was used as positive 
control (in the range 0.016 – 0.025 µg/ml). 
DMSO was tested at 0.125% final concentration. 
Negative control (without extract) was included. 
100 µl of 1% F32 parasitised blood was added to 
all the wells. The plate was incubated in a candle 
jar for 48 hours and the cells fixed on 8-well 
multi–test slides and infected erythrocytes (Ei) 
counted by fluorescence microscopy using 
acridine orange stain. The number of Ei in 25 
microscopic fields (approximately 5000 
erythrocytes) per well was counted (i.e. a total of 
40,000 erythrocytes per test concentration).  The 
percentage parasitaemia after incubation was 
calculated as (Ei ÷ 40,000) x 100. The 
percentage inhibition per concentration was 
calculated using the formula [17]: 
[(% parasitaemia in control wells - % 
parasitaemia  of   test wells)    
        ÷  (% parasitaemia of the control)] x 100   
 
Acute Toxicity Test     
The most active product, compound 1, was 
tested for acute toxicity in vivo in 6N C57 BL 
mice (approximately 20 g body weight). The 
compound (60 µg/g body weight of mouse > 2 x 
IC50) was injected intraperitoneally in each of 
six mice.  DMSO (0.25% per gram body weight) 
was also tested in another group of mice.  This 
test was conducted in accordance with the 
European Community guidelines [18]. 
 
Statistical Analysis 
The experiment was done twice for the most 
active product (compound 1, Figure 1), each 
concentration was tested in duplicate. The 
average percentage inhibition of invasion of the 
two experiments for each concentration is shown 
on Table 1. The Mann–Whitney test was used to 
test for significance in the inhibition of 
erythrocyte invasion by P. falciparum F32 at 
each concentration of compound 1, by 
comparing the eight average Ei values 
corresponding to the eight wells of the multi–test 




Antiplasmodial  Activity 
All the isolated compounds were tested on 
trophozoites. The average percentage inhibition 
of erythrocyte invasion by P. falciparum F 32 in 
the culture for the four compounds ranged from 
16 to 77 % at the highest concentration of 62.5 
µg/ml tested (Table 1). Compound 1 was the 
most active with an IC50 of 26 µg/ml (Figure 2). 
The invasion of erythrocytes by the parasite was 
significantly reduced at each of the four 
concentrations of compound 1 tested relative to 
the control (p = 0.001 to 0.002). The effect of 
compound 1 on erythrocyte invasion is 
illustrated in Figure 2. The negative control had 
a growth rate (parasitaemia) of close to three 
fold after 48 hours incubation (1.5 – 2.9%). We 
recorded an IC50 for chloroquine of 
approximately 0.02 µg/ml. DMSO did not 
inhibit parasite growth at the highest 
concentration (0.125% w/v) used in this assay. 
 
Acute Toxicity Test: -  
No death was recorded in the three groups of six 
mice treated with compound 1, DMSO and the 
untreated control respectively, during the seven 
days of the acute toxicity test. The physical 
activity of the treated mice was indistinguishable 
from the control.  
 
Discussion 
The extracts prepared from the seeds of T. 
africanus (Meliaceae), yielded seven pure 
compounds. Four of them, which were oils, were 
subjected to an in vitro bioassay on Plasmodium 
falciparum F 32, chloroquine-sensitive strain. 
The highest activity was observed with 
Compound 1, with IC50 of 26 µg/ml (Table 1). 
Compounds 2 and 3 showed lower 
antiplasmodial activities (IC50: 51 and 60 µg/ml 
respectively), while the fourth compound, TA3, 
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by people of the Bakweri ethnic group based in the Fako Division in the South West Province of  
      
  Table 1. Inhibition of Plasmodium falciparum F 32 (trophozoite stage) invasion of erythrocytes 
                 by the four compounds isolated from T. africanus 
 
 
   aSlides not counted due to very low inhibition observed at higher concentration. 
   bThe four concentrations of  compound 1 tested produced  significant  inhibition  of  erythrocyte invasion;   
    c,dMann-Whitney statistical significance(p): cp = 0.001, dp = 0.002 
 
Cameroon. The Bakweri people call it 
“mokomo” in their native tongue (Mokwe). We 
recorded an average IC50 of   0.02 µg/ml for 
chloroquine (n =10), almost identical to the 
value (0.021 µg/ml) recorded by Muregi et al 
against chloroquine-sensitive P. falciparum 
K39, isolated from a Kenyan patient  [9], using 
the 3H-hypoxanthine incorporation method. This 
demonstrates the reliability of the fluorescence 
microscopy technique that was used in this 
study.  On this basis, the IC50 of compound 1 is 
high when compared with chloroquine (IC50 = 
0.02 µg/ml) The results show that the individual 
products present in  T. africanus   have weak 
antiplasmodial activity. In the traditional 
medicine practice of the Bakweris, the trunk 
bark and seeds of this plant are boiled together 
with Carica papaya leaves, the seeds of 
Aframomum melegueta and lime and used for 
treatment of malaria. The results serve as 
evidence that at least there is some antimalarial 
activity which supports the claim of traditional 
medicine practitioners and users that the plant is 
active against malaria. The acclaimed 
effectiveness of the stem bark against malaria in 
traditional use is likely as a result of the 
combined effect of the different compounds 
present in it together with the antimalarial 
effects of the other plants used in conjunction 
with it. Bhat and Surolia [19] showed that the 
petroleum ether extracts of the rind and pulp of 
Carica papaya had IC50s of 15.19 and 18.09 
µg/ml respectively against P. falciparum FCF 2, 
a local Indian strain; the methanol and water 
extracts gave IC50s above 100 µg/ml. We have 
recorded an IC50 of 52.5 µg/ml for Carica 
papaya leaves against P. falciparum F 32. 
Labdanes from Aframomum latifolium and 
Aframomum sceptrum of the Zingiberaceae 
family showed a modest in vitro activity against 
a chloroquine-sensitive Plasmodium falciparum 
strain [20]. Aframomum melegueta of the same 
family has been shown to have antipyretic, 
analgesic, anti-tussive and anti-hepatoxic actions 
[21]; inhibits prostaglandin synthesis [22]; and 
has antibacterial and antifungal activity [23, 24] 
but apparently has not been extensively 
investigated for antimalarial activity. It is likely 
    Concentration of compound 
               (µg/mL)  




     %    Inhibition of Invasion 
Approximate        
        IC50 
      (µg/mL) 
1 1b 76.8c 52.7c 42.8d 34.6d        26 
2 2 54 13.3    a  a        51 
3 TA 3 16.6   a    a  a    >>60 
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that these plants used traditionally together with   
T. africanus contribute to the observed 
antimalarial activity, however this combined 
effect and its clinical efficacy remains to be 
demonstrated experimentally. Figure 2 shows a 
dose-related inhibition of erythrocyte invasion 
suggesting that compound 1 may be acting on a 
specific target in the Plasmodium parasite. At 
each of the four concentrations of compound 1 
there was a significant reduction of erythrocyte 
invasion relative to the control (p = 0.001 to 
0.002 from 62.5 to 7.8 µg/ml respectively). 
 
                                         Fig 2. Inhibition of P falciparum F 32 (trophozoite stage) invasion  
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Compound 1 is known to be cytotoxic in vitro 
[11], but the compound did not show any acute 
toxicity in mice at greater than twice its IC50 per 
gram body weight (60 µg/g body weight). 
However a more extensive toxicity study is 
required to better assess the safety of the 
compound. From the above findings, compound 
1 is the most active component from T. 
africanus probably acting in an additive mode or 
in synergy with the other compounds present in 
it and in the other plants with which it is 
combined in traditional use. In vivo 
biotransformation of compound 1 and the other 
compounds may produce intermediates that may 
be more active against the malaria parasite 
compared to the in vitro activity but this also 
remains to be demonstrated. 
 
Conclusion  
The results show that T. africanus has weak 
antiplasmodial activity, which probably when 
combined with other antiplasmodial plants (C. 
papaya and A. melegueta) results in an enhanced 
antimalarial effect which is exploited in the 
traditional medicine of the Bakweris as an 
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